This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 05/21/2020
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Patient groups, providers, industry, academia, and other stakeholders

Event Date: 05/21/2020
Location: Virtual
Subject: UCSF-Stanford Centers of Excellence in Regulatory Science and Innovation (CERSI) Scientific Advisory Board Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Represenatives from industry, academia, and other stakeholders

Event Date: 05/22/2020
Location: Virtual
Subject: Vaccines and Data for COVID-19
FDA Participant/Group: MIMI NGUYEN; LORRIE MCNEILL; LAURA CALIGUIRI; EMILY HELMS WILLIAMS; PETER MARKS; JULIA TIERNEY; STEVE MORIN; GINA VALO; DAYLE CRISTINZIO; SARAH LYNCH; COLIN ROM; JOSEPH FRANKLIN;
Non FDA Participant/Group: Rob Lenz (Amgen); James Mayne, Kelly Goldberg, Lucy Vereshchagina, Mary Kosinski, Richard Moscicki (PhRMA); Liz Roberts (UCB); J.R. Meloro (Pfizer); Eddie Reilly (Sanofi); John Tsai (Novartis); Mathai Mammen (Janssen/J&J); Annetta Beauregard (Johnson & Johnson); Tim Montague (GSK); Carl Garner (Eli Lilly); Anne Heatherington (Takeda);

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/20/2020
Location: Virtual
Subject: Food Safety and Supply Chain Issues in Response to COVID-19
FDA Participant/Group: KARI BARRETT; SUSAN MAYNE; MARK MOORMAN;
Non FDA Participant/Group: Several executives from the food industry

Event Date: 05/20/2020
Location: Virtual
Subject: Leafy Greens Investigation Report
FDA Participant/Group: N/A
Non FDA Participant/Group: Rep. Jimmy Panetta (D-CA);

Event Date: 05/21/2020
Location: Virtual
Subject: United States-Canada Joint Committee on Food Safety
FDA Participant/Group: Several FDA staff members
Non FDA Participant/Group: Several executives and staff from Health Canada and Canadian Food Inspection Agency

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event